This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Innovations in Gene Therapy by Ming Cheng Gu
Introduction
Ming Cheng Gu is an accomplished inventor based in Lansdale, PA (US). He has made significant contributions to the field of gene therapy, particularly in addressing leptin deficiency, which is a critical factor in obesity management.
Latest Patents
Ming Cheng Gu holds a patent for a groundbreaking gene therapy aimed at treating obesity in mammals. His patent, titled "Gene therapy for leptin deficiency," involves the use of an adenoviral vector that encodes a leptin gene. This vector is delivered intravenously to mammals with a deficiency in functional leptin, resulting in decreased weight, lower serum insulin levels, and reduced serum glucose levels. This innovative approach has the potential to transform obesity treatment.
Career Highlights
Ming Cheng Gu is currently employed at Merck & Co., Inc., where he continues to advance research in gene therapy and its applications. His work is pivotal in developing therapeutic strategies that can significantly improve health outcomes for individuals suffering from obesity-related conditions.
Collaborations
Ming Cheng Gu collaborates with esteemed colleagues, including Manal A Morsy and C Thomas Caskey. Their combined expertise fosters a dynamic research environment that enhances the development of innovative therapies.
Conclusion
Ming Cheng Gu's contributions to gene therapy represent a significant advancement in the fight against obesity. His innovative patent and ongoing work at Merck & Co., Inc. highlight the importance of research in developing effective treatments for metabolic disorders.